|
Groups
|
GSH-PX (U/mgprot)
|
T-SOD (U/mgprot)
|
MDA (nmol/mgprot)
|
|---|
|
Normal
|
81.57 ± 5.48
|
210.50 ± 2.37
|
0.68 ± 0.10
|
|
Model
|
49.68 ± 6.89**
|
131.99 ± 10.19**
|
1.57 ± 0.31**
|
|
1% GD
|
61.10 ± 6.34
|
138.79 ± 3.78#
|
1.24 ± 0.19
|
|
5% GD
|
68.43 ± 7.49#
|
184.35 ± 10.02##
|
0.97 ± 0.09#
|
|
10% GD
|
76.05 ± 5.31##
|
197.18 ± 7.74##
|
0.79 ± 0.10#
|
- 1% GD, 1% GD-treated diabetic group; 5% GD, 5% GD-treated diabetic group; 10% GD, 10% GD-treated diabetic group. The experimental data are presented as means ± SD. **P < 0.01, respectively, versus normal group; #P < 0.05 and ##P < 0.01, respectively, versus diabetic model group
